G. Manikhas

G. Manikhas, A. Kalugina, N. Tapilskaya, 2019, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

Spontaneous pregnancy after transplantation of cryopreserved ovarian tissue: a case report

G. Manikhas, A. Kalugina, A. Lisyanskaya, 2019 .

An open randomised trial of second-line endocrine therapy in advanced breast cancer. comparison of the aromatase inhibitors letrozole and anastrozole.

R. Thomas, G. Manikhas, C. Rose, 2003, European journal of cancer.

Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study.

J. Baselga, B. Leyland-Jones, V. Semiglazov, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

Clement Adebamowo, Ritika Kundra, Steven J. M. Jones, 2018, Cell reports.

A Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors

Branimir Sikic, David C. Smith, Rashmi Chugh, 2014, Clinical Cancer Research.

Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.

Steven J. M. Jones, Benjamin J. Raphael, Mark D. M. Leiserson, 2017, Cancer cell.

Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAF V600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial

P. Ascierto, H. Gogas, P. Rutkowski, 2020, The Lancet.

Comparable activity with oral topotecan/cisplatin (TC) and IV etoposide/cisplatin (PE) as treatment for chemotherapy-naive patients (pts) with extensive disease small cell lung cancer (ED-SCLC): Final results of a randomized phase III trial (389)

G. Manikhas, J. Eckardt, Z. Pápai, 2005 .

Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors.

G. Manikhas, A. Komissarov, O. Kiselev, 2017, Oncotarget.

Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial.

J. Milanowski, J. Strausz, R. Ramlau, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomised, double-blind, placebo-controlled phase 2 study of trebananib (AMG 386) in combination with FOLFIRI in patients with previously treated metastatic colorectal carcinoma

G. Manikhas, M. Peeters, N. Tebbutt, 2013, British Journal of Cancer.

A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy.

A. Macciocchi, F. Lordick, M. Aapro, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[Laparoscopic surgery in treatment for colon cancer].

G. Manikhas, M. Fridman, E. G. Topuzov, 2015, Voprosy onkologii.

Pegylated liposomal doxorubicin plus docetaxel significantly improves time to progression without additive cardiotoxicity compared with docetaxel monotherapy in patients with advanced breast cancer previously treated with neoadjuvant-adjuvant anthracycline therapy: results from a randomized phase II

Liang Xiu, N. Bogdanova, J. Sparano, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II genomics study of ixabepilone as neoadjuvant treatment for breast cancer.

J. Baselga, E. Kubista, Li-an Xu, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparative evaluation of treatment methods of neoadjuvant intra-arterial chemotherapy and chemoembolization by drug-saturated embospheres in II–IVa stages cervical cancer

G. Manikhas, M. A. Kukanov, S. G. Parsyan, 2019, Tumors of female reproductive system.

Biomarkers as potential predictors of pathologic complete response (pCR) in the NOAH trial of neoadjuvant trastuzumab in patients (pts) with HER2-positive locally advanced breast cancer (LABC)

L. Pusztai, J. Baselga, W. Eiermann, 2008 .

Neoadjuvant trastuzumab in locally advanced breast cancer (NOAH): Antitumour and safety analysis

J. Baselga, W. Eiermann, A. Lluch, 2007 .

Phase II genomics study in patients receiving ixabepilone as neoadjuvant treatment for breast cancer (BC): Preliminary efficacy and safety data

J. Baselga, E. Kubista, G. Manikhas, 2005 .

Phase I, dose-finding study of AZD8931, an inhibitor of EGFR (erbB1), HER2 (erbB2) and HER3 (erbB3) signaling, in patients with advanced solid tumors

G. Manikhas, S. Tjulandin, U. Keilholz, 2014, Investigational New Drugs.

A phase I study of talotrexin (PT-523) in patients with relapsed or refractory non-small cell lung cancer (NSCLC).

G. Manikhas, A. Dowlati, J. Garst, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abstract P2-16-06: Final Overall Survival Results, Including Analysis of Patients with Triple-Negative Disease and Aged ≥70 Years, from the ATHENA Study Evaluating First-Line Bevacizumab-Containing Therapy for Locally Recurrent/Metastatic Breast Cancer

G. Manikhas, J. Pierga, C. Thomssen, 2010 .

Biomarker analyses from the phase III placebo-controlled SATURN study of maintenance erlotinib following first-line chemotherapy for advanced NSCLC.

F. Cappuzzo, W. Brugger, N. Triller, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer.

F. Cappuzzo, W. Brugger, N. Triller, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer: primary efficacy analysis of the NOAH trial.

J. Baselga, W. Eiermann, A. Lluch, 2009 .

A Phase I Dose Escalation and Expansion Study of the Anticancer Stem Cell Agent Demcizumab (Anti-DLL4) in Patients with Previously Treated Solid Tumors

David C. Smith, B. Sikic, G. Manikhas, 2014, Clinical Cancer Research.

Correction to: Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis.

G. Manikhas, A. Coomarasamy, S. Fishel, 2022, Human Reproduction Update.